A New Milestone for EchoLaser and ModìLite: Supporting Clinical Excellence
We are proud to announce a new and significant achievement for our EchoLaser and ModìLite technologies: they have been selected by the Endocrine Surgery Unit at the Vanvitelli University Hospital in Naples, led by Professor Domenico Parmeggiani, for the treatment of thyroid disorders.
This important milestone once again confirms the clinical value of EchoLaser, renowned for its effectiveness, safety, and minimally invasive approach—features that continue to earn the trust of both medical professionals and patients.
Collaborating with centers of excellence such as the Vanvitelli University Hospital strengthens our mission: to provide cutting-edge therapeutic solutions that improve patients’ quality of life and support healthcare professionals with innovative and reliable technologies.
We extend our sincere thanks to the entire team at Vanvitelli University Hospital for their trust and collaboration.
EchoLaser International Collaboration: Prof. Abou-Taleb’s Clinical Tour in Italy
Over the past few days, we had the pleasure of welcoming Prof. Abou Taleb to Italy for a tour of top centers specializing in EchoLaser TPLA treatments.
📍 In Pisa, at Ospedale Cisanello, he met with Prof. Riccardo Bartoletti and Dr. Matteo Pacini.
https://lnkd.in/ddMg8PDN
📍 In Bergamo, at Clinica San Francesco – Casa di Cura Privata, he was hosted by Dr. Gianluigi Patelli and Dr. Vincenzo Altieri.
https://lnkd.in/dNrVnWfg
📍 Finally, in Florence, at Azienda Ospedaliero-Universitaria Careggi, he joined Dr. Francesco Sessa and Dr. Paolo Polverino, where he also received training on the UroFusion system from Esaote for targeted prostate biopsies and focal therapy.
https://lnkd.in/dMamC6c8
A heartfelt thank you to all the outstanding professionals involved for their warm welcome, expertise, and dedication. International clinical exchange is a key driver for advancing safe, effective, and innovative medical care. 🌍🤝
🙏 Special thanks also to Rocamed SAM, licensee of the EchoLaser technology, and to Mediclass, our distributor in Egypt, for their continued support in making this collaboration possible.
EchoLaser is now NMPA approved
Elesta announces that the Chinese regulatory authority National Medical Products Administration (NMPA) has approved EchoLaser for use in prostatic diseases. This approval is a major achievement and represents a great opportunity for Elesta (distributed in China by Esaote). NMPA approval confirms once again the robustness of clinical data in urology, where EchoLaser has been demonstrated to be a safe and efficacious alternative to surgery for the treatment of Benign Prostatic Hyperplasia (BPH) and some forms of prostatic cancer.
New office dedicated to the EchoLaser in Cisanello, Pisa
Exciting News in Medical Innovation!
Promotional Material
Fill in the following form to receive commercial and / or promotional communications